文献速递乳腺乳腺X线

对比增强乳腺X线摄影与传统影像在筛查后召回女性诊断检查中的成本效果:RACER试验

Cost-effectiveness of contrast-enhanced mammography compared to conventional imaging in the work-up after screening (RACER trial).
PubMed 文献 · Eur Radiol · 2025-12-24

基于RACER随机对照试验的医院视角经济学评价显示,以对比增强乳腺X线摄影(CEM)作为筛查召回后诊断检查的主要工具,总成本较传统影像低117欧元(95%CI -254; +22),影像成本显著降低130欧元(95%CI -153; -105),QALY相近(CEM组1.2034 vs 对照组1.2137)。在BI-RADS 0召回亚组中CEM具有成本效果的概率为85%,总体为53%(阈值10000欧元/QALY损失)。

要点

  • CEM作为筛查召回后主要诊断工具,影像成本较传统影像显著降低130欧元(95%CI -153; -105)。
  • BI-RADS 0召回亚组中CEM具有成本效果的概率为85%,作者建议该亚组以CEM替代传统影像。
  • 其他召回亚组中CEM具有成本效果的概率为53%,作者认为应强烈考虑使用CEM。

核心结论

  • CEM作为筛查召回后诊断检查的主要工具是一种具有成本效果的诊断策略,尤其在BI-RADS 0召回中;在其他召回中,CEM应被强烈考虑。

研究设计与样本

  • 基于随机对照RACER试验的医院视角经济学评价,成本价格取自马斯特里赫特大学医学中心财务部门,采用EQ-5D-5L问卷在18个月内测量5次健康相关生活质量,缺失数据采用多重插补,并采用非参数bootstrap分析成本与每QALY增量成本的不确定性,事后按BI-RADS召回评分进行亚组分析。

诊断标准与关键数值

  • CEM组总成本较传统影像组低117欧元(95% CI -254; +22),差异未达统计学显著。
  • CEM组平均影像成本较传统影像组低130欧元(95% CI -153; -105),差异达统计学显著。
  • CEM组平均QALY为1.2034,对照组为1.2137。
  • bootstrap分析显示95%模拟ICER位于提示成本节约的象限,其中25%的ICER显示QALY小幅增益、70%显示QALY小幅损失。
  • 在10000欧元/QALY损失的阈值下,CEM具有成本效果的概率总体为53%,BI-RADS 0召回亚组为85%。

临床应用与阅片要点

  • 作者认为在BI-RADS 0(低怀疑)召回中,应以CEM作为主要影像方法替代传统影像。
  • 作者认为在其他召回中,应强烈考虑使用CEM。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The randomised controlled clinical RACER trial studied the diagnostic work-up with contrast-enhanced mammography (CEM) compared to conventional imaging as the primary tool in women recalled from breast cancer screening. This current trial-based economic evaluation was performed from a hospital perspective.

MATERIALS AND METHODS: Cost prices were retrieved from the financial departments of the Maastricht University Medical Centre. Health-related quality of life was measured five times over 18 months using the EQ-5D-5L questionnaire. Cost-utility analysis outcome was expressed as costs per quality-adjusted life year (QALY). Multiple imputation was used for missing data, and non-parametric bootstrap analysis was performed to examine uncertainty in the difference in costs and incremental costs per QALY. Post hoc subgroup analysis was performed per BI-RADS recall score.

RESULTS: Work-up with CEM showed lower total costs of €-117 (95% CI €-254; €+22) compared to conventional imaging. Average imaging costs were significantly lower with CEM (mean difference €-130; 95% CI €-153; €-105). Mean QALY for the CEM group was 1.2034 versus 1.2137 for the control group. Bootstrap analysis showed that 95% of all simulated ICERs were in the quadrants that indicate cost-savings, although 25% of the ICERs showed a small gain in QALY and 70% a small QALY loss. The probability of CEM being cost-effective is 53% at a threshold of €10,000 to accept a QALY loss. In the subgroup of BI-RADS 0 recalls, specifically, this probability is 85%.

CONCLUSION: CEM as a primary tool in the diagnostic work-up is a cost-effective diagnostic strategy, especially in BI-RADS 0 recalls.

KEY POINTS: Question Diagnostic accuracy is similar with contrast-enhanced mammography (CEM) compared to conventional as primary imaging. However, while the work-up is more efficient, is it also a cost-effective strategy? Findings Using CEM as primary imaging tool in the diagnostic work-up of recalls from screening results in lower costs with similar QALY compared to conventional imaging. Clinical relevance In BI-RADS- 0 (low suspicion) recalls, CEM should be used as primary imaging modality instead of conventional imaging. CEM compared to conventional imaging in the work-up of recalled women is cost-effective. In other recalls, CEM should be strongly considered.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Neeter LMFH, Lobbes MBI, Duvivier KM, et al. Cost-effectiveness of contrast-enhanced mammography compared to conventional imaging in the work-up after screening (RACER trial). Eur Radiol. 2025. PMID: 41441997. doi:10.1007/s00330-025-12195-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。